Login
Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Password:
Stay Logged In


Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Assay Kits  >  MMP Assay Kits  >>  SensoLyte® 520 MMP-2 Assay Kit *Fluorimetric*

Product Name SensoLyte® 520 MMP - 2 Assay Kit *Fluorimetric*
Size 1 kit
Catalog # AS-71151
US$ $435
Description

Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. The importance of MMPs in tumor development and invasion is well known. MMP-2 (gelatinase A) is proposed as a potential therapeutic target. SensoLyte® 520 MMP-2 Assay Kit uses a 5-FAM (fluorophore) and QXL520™ (quencher) labeled FRET peptide substrate for continuous measurement of the enzyme activities. In an intact FRET peptide, the fluorescence of 5-FAM is quenched by QXL520™. Upon the cleavage of the FRET peptide by MMP-2, the fluorescence of 5-FAM is recovered, and can be continuously monitored at excitation/emission = 490 nm/520 nm. With superior fluorescence quantum yield and longer emission wavelength, 5-FAM/QXL520™ based FRET peptide is less interfered by the autofluorescence of test compounds and cellular components and provides better assay sensitivity. The assays are performed in a convenient 96-well or 384-well microplate format.

Kit size:100 assays

Detailed Information Datasheet
Material Safety Data Sheets (MSDS)
Brochure
Storage -20°C
Product Citations Liu, B. et al. (2014). Endothelin A receptor antagonism enhances inhibitory effects of anti-ganglioside GD2 monoclonal antibody on invasiveness and viability of human osteosarcoma cells. PloS one 9, e93576.
Pifer, MA. et al. (2014). Matrix metalloproteinase content and activity in low-platelet, low-leukocyte and high-platelet, high-leukocyte platelet rich plasma (PRP) and the biologic response to PRP by human ligament fibroblasts. Am J Sports Med 42, 1122. doi: 10.1177/0363546514524710.
Spolidoro, M. et al. (2012). Inhibition of matrix metalloproteinases prevents the potentiation of nondeprived-eye responses after monocular deprivation in juvenile rats. Cereb Cortex, 22, 725-734.
Jo, YK. et al. (2011). ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells. Biochem Biophys Res Commun 404, 1039.
Qazi, H. et al. (2011). Fluid shear stress regulates the invasive potential of glioma cells via modulation of migatory activity and matrix metalloproteinase expression. PLoS One 6, e20348.
Yuan, H. et al. (2010). A novel pharmacophore model for the design of anthrax lethal factor inhibitors. Chem Biol Drug Design 76, 263.
Rahn, D. et al. (2009). Failure of pelvic organ support in mice deficient in fibulin-3. Am J Pathol 174, 206.
Shi, Z-D. et al. (2009). Interstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3-D collagen I via upregulation of MMP-1. Am J Physiol Heart Circ Physiol 10.1152/ajpheart.00369.2009.
Wieslander, C. et al. (2009). Quantification of pelvic organ prolapse in mice: Vaginal protease activity precedes increased MOPQ scores in fibulin 5 knockout mice. Biol Reprod 80, 407.
Johnson, SL. et al. (2008). A high-throughput screening approach to anthrax lethal factor inhibition. Chem Bio Drug Design 71, 131.
Wieslander, S. et al. (2008). Regulation of elastolytic proteases in the mouse vagina during pregnancy, parturition, and puerperium. Biol Reprod 78, 521.
     
  < Back